Intelligent Infusion Management System Market Growth, Trends and Forecast
According to Rohan Patil, who specializes in the Therapeutic Area industry with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the intelligent infusion management system market. The global intelligent infusion management system market size was estimated at USD 1.15 billion in 2025 and is predicted to increase from USD 1.23 billion in 2026 to approximately USD 2.29 billion by 2035, expanding at a CAGR of 7.14% from 2026 to 2035. His evaluation shows that intelligent infusion technology has rapidly gained popularity; as well as supporting this trend by highlighting its benefits of improving medication safety, integrating EHRs, helping healthcare providers move towards digital solutions, increasing interest in wireless connectivity, facilitating real-time monitoring, and utilizing big data to enhance clinical decision making and reduce medication errors. In addition to the above findings; the market is predicted to grow due to increased hospital expenditures on connected healthcare infrastructure, ongoing government legislation that supports patient safety, increasing incidence of chronic diseases, and rising demand for automated drug delivery systems (IDS) across hospitals, ambulatory care centres and specialty clinics. The study also looks at the strategies used by traditional competitors in the marketplace such as Becton, Dickinson and Company (BD), Baxter International Inc., ICU Medical, Inc., B. Braun SE, Fresenius Kabi AG and Smiths Medical, among others, that are expected to impact the future landscape of the global intelligent infused management system market.
Last Updated : 30 June 2026
Category: Therapeutic Area
Insight Code: 6656
Format: PDF / PPT / Excel